Drug Costs

Line Art 1
Line Art 2
Line Art 3
Line Art 4
As Seen In: SHRM

GLP-1 pills are here: What does it mean for employers?

Will GLP-1 pills change how employers approach coverage? It’s an important question, but the answer isn't so straightforward.

As Seen In: EBN

As Ozempic costs fall, demand for weight-loss drugs is set to surge

On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP…

Direct access isn’t a program – it’s market design

Welcome to a direct access marketplace, where incentives are aligned by design so access becomes the default outcome.

As Seen In: Reuters

Data shows US advertising spend increasing for pharma manufacturers

Even with increased availability, access to GLP-1 therapies can be challenging for employers and healthcare consumers due to…

Redefining drug access: How the Direct Marketplace helps transform sustainable drug pricing, patient affordability, and innovation 

For decades, the U.S. drug distribution model has depended on a complex web of intermediaries — pharmacy benefit…

As Seen In: EBN

A broker’s guide to breaking the rebate cycle

Prescription drug costs are among the fastest-growing and most unpredictable healthcare expenses employers face. According to recent data,…

As Seen In: Drug Topics

Navigating GLP-1 access & complexity: 4 key insights

Glucagon-like peptide-1 (GLP-1) therapies are reshaping care for diabetes, obesity, and cardiometabolic health. Yet with their rapid rise…

Prescryptive Secures HITRUST Certification, Enabling Trusted Engagement Across the Consumer-Centric Ecosystem

HITRUST e1 Certification affirms Prescryptive’s secure platform for healthcare participants building trusted, modern pharmacy solutions. Redmond, WA, September…

As Seen In: BenefitsPRO

Could voluntary prescription plans help small employers ease the squeeze?

As healthcare costs continue to burden small businesses, voluntary prescription plans could be a compelling solution for employers…

As Seen In: BenefitsPRO

With tariffs in the mix, pharmacy benefits deserve a second look

Prescryptive’s SVP of Payer Solutions, Rae McMahan, offers timely insights in her new article in BenefitsPRO, “With tariffs in…

As Seen In: Newsweek

Store Closures On Track to Far Exceed 2024 Levels

In a recent Newsweek article highlighting the surge of U.S. store closures—5,822 so far this year, compared to…

Demystifying Prior Authorizations: Putting power back in healthcare consumers’ hands  

In the complex world of healthcare, one of the most frustrating hurdles for healthcare consumers can be the…